Over the last year, diabetes technology saw significant changes, including the acceleration of patch pumps, ever-smaller continuous glucose monitors (CGM), implanted CGMs and increased interest in ...
Palomar Holdings, Inc. is rated a Buy with Gray's M&A deal and a potential Q425 beat. Learn more about PLMR stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback